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reversible MM kinetics has been introduced to describe the transport 
process (Cunningham et al., 1986; Gruetter et al., 1998). The revers-
ible MM kinetics of glucose transport implies a near linear relation 
between brain and plasma glucose, as it has been experimentally 
determined in several studies in both humans (e.g. Gruetter et al., 
1998) and rats (e.g. Choi et al., 2002). The reversible MM equation 
previously derived (Cunningham et al., 1986; Gruetter et al., 1998) 
reliably describes the relationship of brain to plasma glucose but it 
has not been taken as a general model because it is unable to account 
for features of the glucose carrier that include trans-acceleration or 
asymmetry (Barros et al., 2007). On the other hand, a conforma-
tional four-state exchange kinetic model of simple solute carriers 
(e.g. Cuppoletti and Segel, 1975) can account trans-acceleration, 
product inhibition and asymmetry (Carruthers, 1990), and was used 
in a recently developed multi-compartmental theoretical model of 
brain glucose transport (Barros et al., 2007).
Recently developed models describe the dynamics of brain glu-
cose transport over time but require many unknown parameters 
and can only be solved by numerical analysis (e.g. Barros et al., 
2007; Simpson et al., 2007). The aim of the present study was to 
develop a single analytical expression based on the  aforementioned 
  conformational four-state exchange model of carriers to describe 
INTRODUCTION
Brain function relies on glucose supply from blood, which occurs 
through membrane-spanning proteins that are facilitative car-
riers located at the blood-brain-barrier (BBB). There are sev-
eral glucose carrier isoforms present in the brain. However, the 
predominant glucose transporter (GLUT) proteins involved in 
cerebral glucose utilization are GLUT1 and GLUT3, GLUT1 being 
present in all brain cells including the endothelial cells of the 
capillaries (and with very low neuronal expression in vivo), and 
GLUT3 almost restricted to neurons (reviewed in Simpson et al., 
2007). Therefore, GLUT1 is considered the principal carrier of 
glucose at the BBB.
The process of glucose transport in the brain is saturable (Crone, 
1965) but not rate limiting for the glycolytic pathway (Betz et al., 
1976). Models of glucose transport across the BBB were devel-
oped based on standard Michaelis-Menten (MM) kinetics (e.g. 
Lund-Andersen, 1979). However, since brain glucose can achieve 
 concentrations similar to or higher than the KM of the glucose carrier, 
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Glucose supply from blood to brain occurs through facilitative transporter proteins. A near linear 
relation between brain and plasma glucose has been experimentally determined and described 
by a reversible model of enzyme kinetics. A conformational four-state exchange model accounting 
for trans-acceleration and asymmetry of the carrier was included in a recently developed multi-
compartmental model of glucose transport. Based on this model, we demonstrate that brain 
glucose (Gbrain) as function of plasma glucose (Gplasma) can be described by a single analytical 
equation namely comprising three kinetic compartments: blood, endothelial cells and brain. 
Transport was described by four parameters: apparent half saturation constant Kt, apparent 
maximum rate constant Tmax, glucose consumption rate CMRglc, and the iso-inhibition constant 
Kii that suggests Gbrain as inhibitor of the isomerisation of the unloaded carrier. Previous published 
data, where Gbrain was quantiﬁ  ed as a function of plasma glucose by either biochemical methods 
or NMR spectroscopy, were used to determine the aforementioned kinetic parameters. Glucose 
transport was characterized by Kt ranging from 1.5 to 3.5 mM, Tmax/CMRglc from 4.6 to 5.6, and 
Kii from 51 to 149 mM. It was noteworthy that Kt was on the order of a few mM, as previously 
determined from the reversible model. The conformational four-state exchange model of glucose 
transport into the brain includes both efﬂ  ux and transport inhibition by Gbrain, predicting that Gbrain 
eventually approaches a maximum concentration. However, since Kii largely exceeds Gplasma, 
iso-inhibition is unlikely to be of substantial importance for plasma glucose below 25 mM. As 
a consequence, the reversible model can account for most experimental observations under 
euglycaemia and moderate cases of hypo- and hyperglycaemia.
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steady-state glucose transport across the BBB with only three 
unknown constants. The analytical equation that was now  developed 
was tested with previously measured relationships between brain 
and plasma glucose concentrations and compared to both the 
reversible and standard MM models.
MATERIALS AND METHODS
KINETIC MODEL OF GLUCOSE TRANSPORT
Glucose selectively binds to facilitative glucose carriers that medi-
ate solute movement in both directions of the BBB. This facilitated 
diffusion is dependent on the concentration gradient, which is 
maintained by phosphorylating intracellular glucose thus achiev-
ing continued net uptake. Non-carrier mediated diffusion of glu-
cose molecules through the plasma membrane was assumed to be 
negligible as generally observed (e.g. Gruetter et al., 1998; Barros 
et al., 2007). As referred before, it was considered that GLUT1 is 
the main responsible for the facilitative transport of glucose across 
the BBB (Simpson et al., 2007).
Figure 1A represents the alternating-conformation model for 
a membrane carrier (e.g. Cuppoletti and Segel, 1975), for which 
Eq. 1 can be derived using the King-Altman method (King and 
Altman, 1956) and the deﬁ  nitions proposed by Cleland (1963), as 
shown in Section “Derivation of the Net Velocity Equation for the 
Four-State Exchange Model” in Appendix.
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In Eq. 1, v0 is the net transport across the carrier, Vmax is the 
  maximum velocity of the forward transport, Gout and Gin are the 
glucose concentrations in the outer and inner compartments, K
G
M
out 
and K
G
M
in are the Michaelis constants for the forward and reverse 
transports, Keq is the equilibrium constant for the overall reaction, 
which is 1 for facilitated diffusion processes such as brain glucose 
transport (discussed in Cuppoletti and Segel, 1975), and Kii is an 
inhibition constant, in particular the iso-inhibition constant reﬂ  ect-
ing the inhibition of Gout transport by Gin (Segel, 1993).
From Eq. 1, we note that the inhibition constant Kii represents the 
Gin at which the velocity of glucose uptake is half of the maximum 
under saturating Gout (i.e. when GK
G
out M
out  ). Classic   enzymology 
predicts that Gin in the system described by this equation acts 
as a mixed (or noncompetitive) inhibitor of the glucose carrier 
(Leskovac, 2003).
In the derivation of Eq. 1, considering that the isomerisa-
tion rate of the unloaded carrier is faster than the other con-
formational changes is equivalent to the assumption of a single 
conformation for the unloaded carrier (see “Derivation of the 
Four-State Conformational Model Assuming Fast Isomerisation 
of the Unloaded Carrier” in Appendix). In that case, the expression 
derived for the net velocity matched the equation derived for the 
reversible MM model with two carrier-glucose intermediate com-
plexes. This suggests that Kii is a kinetic parameter that represents 
the isomerisation between the unloaded carriers at the membrane 
(depicted as Cout and Cin in Figure 1A), being the eventual product 
inhibition related to the maintenance of the carrier in a conforma-
tion that facilitates the binding of Gin.
In the numerical analysis of glucose transport at the BBB by Barros 
et al. (2007), the best description of experimental   observations by 
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FIGURE 1 | (A) Schematizes the alternating-conformation kinetics of the glucose 
carrier. In the absence of glucose (Gout or Gin), the carrier can exist in two inter-
converting isomers that are ready to bind glucose either outside (Cout) or inside 
(Cin) the membrane. When loaded, the carrier can also assume two isomeric 
forms favouring glucose release to the outer (CoutG) or inner (CinG) side of the 
membrane. The rate constants k1 and k−3 deﬁ  ne glucose binding while k−1 and k3 
deﬁ  ne its dissociation from the carrier. The rate constants k2 and k−2 or k4 and k−4 
reﬂ  ect the isomerisation of the loaded or unloaded carrier. Panel (B) Shows the 
simplest model of bidirectional glucose transport (T f and Tr) represent the 
forward and reverse ﬂ  uxes of glucose diffusion) through a BBB that was 
considered as a single membrane. In panel (C), the compartment composed by 
the endothelial cells was included and thus four unidirectional ﬂ  uxes (T) are 
required to describe glucose ﬂ  ow through the BBB. The glucose consumption 
rate CMRglc was considered as a metabolic compartment in the system.Frontiers in Neuroenergetics  www.frontiersin.org  October  2009 | Volume  1 | Article  6 | 3
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a conformational four-state exchange model included   symmetric 
rather than asymmetric glucose carriers. Carrier   asymmetry is 
pertinently analysed in Section “Asymmetry of the Carrier” in 
Appendix, which suggests that the maximum rate of glucose trans-
port is largely unaffected by the presence of asymmetric carriers 
at the BBB. Therefore, assuming kinetic symmetry of the carrier, 
Eq. 1 can be simpliﬁ  ed to:
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where Vmax is the maximum apparent velocity of the forward 
transport and KM is the Michaelis constant for both forward and 
reverse transport.
Glucose transport across the BBB was described as a three com-
partment system as in previous studies (e.g. Cunningham et al., 
1986; Mason et al., 1992; Gruetter et al., 1998): the BBB separates 
the blood circulation compartment from the brain aqueous phase, 
which is kinetically separated from the metabolic pool where glucose 
is consumed. In this model, the physical distribution space of glucose 
at steady-state was assumed to equal the brain water phase, which 
implies that glucose is evenly distributed in the intra- and extracel-
lular spaces (discussed in Lund-Andersen, 1979; Pfeuffer et al., 2000) 
and that transport across cellular membranes is fast compared to 
glucose consumption rate. In a ﬁ  rst approach, the BBB was assumed 
to behave as a single membrane (Figure 1B). Since there is a rela-
tively small distribution space for glucose inside endothelial cells 
and the rate of transport is fast when compared to consumption 
(Simpson et al., 2007), this approximation is valid at steady-state. 
As referred above, transport across the BBB was described using a 
composition of unidirectional ﬂ  uxes and symmetric kinetic con-
stants for inﬂ  ux and efﬂ  ux. The fraction of blood volume in the 
brain depends on the experimental conditions that affect subject 
physiology (Shockley and LaManna, 1988). With a blood volume 
of 3% and a dry weight of 20%, the size of the entire aqueous phase 
(Vd) was considered 77% of brain’s volume (Lund-Andersen, 1979). 
Cerebral glucose consumption rate was considered to be invariable 
in the range of glucose concentrations analysed.
At steady-state, inward transport (T f) matches outward trans-
port (T r) plus glucose consumption, i.e. brain glucose is described 
by the expression:
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where Gbrain is the glucose in the brain (in µmol g−1), T is the rate of 
glucose inﬂ  ux (T f) or efﬂ  ux (T r) across the BBB (in µmol g−1 min−1), 
and CMRglc is the cerebral metabolic rate for glucose consumption 
(in µmol g−1 min−1), schematised in Figure 1B.
By inserting Eq. 2 in Eq. 3, the relation between glucose concentra-
tions in brain and plasma at steady-state can then be described by:
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where Gbrain and Gplasma are the concentrations of glucose in brain 
(in µmol g−1) and in plasma (in mM), Tmax denotes the apparent 
maximal transport rate across the BBB (µmol g−1 min−1), Kt and Kii 
denote the apparent Michaelis and inhibition constants (in mM), 
Vd is the volume of the physical distribution space of glucose in 
the brain (0.77 mL/g).
From Eq. 4, it is apparent that when Kii equals Kt, the equation 
is formally equivalent to the equation deduced for the standard 
MM kinetics (see Gruetter et al., 1998). We also note that if Kii 
largely exceeds Gplasma, Eq. 4 approximates the form derived for the 
reversible MM model previously described (Gruetter et al., 1998). 
As stated above and shown in Section “Derivation of the Four-
State Conformational Model Assuming Fast Isomerisation of the 
Unloaded Carrier” in Appendix, the reversible MM model is equiva-
lent to the four-state conformational model with a fast exchange 
rate between unloaded carrier conformations (see Eq. A5).
TRANSPORT MODEL INCLUDING ENDOTHELIAL COMPARTMENT
In the model described above, glucose uptake by the brain was 
simpliﬁ  ed to be across a single membrane, which reduced the 
modelled system to the minimum number of required compart-
ments. In reality, other physical compartments must be con-
sidered when glucose diffuses between the blood stream and 
the cytosol of brain cells where glucose is phosphorylated by 
hexokinase. Endothelial cells and interstitial space are two com-
partments that must be considered between the blood and the 
brain cells. A single but complex expression can be derived for a 
model that includes all these compartments, as shown in Section 
“Transport Model Including Both Endothelial and Interstitial 
Compartments” in Appendix.
However, while the distribution of GLUT1 in the luminal and 
abluminal membranes of the endothelium is on the same order 
of magnitude (e.g. Simpson et al., 2007), glucose transporter pro-
teins are more concentrated in the membrane of brain cells than in 
membranes of the endothelium (discussed in Barros et al., 2007). 
Accordingly, the diffusion across the membranes of astrocytes and 
neurons is not limiting for the global rate of glucose transport 
and thus the interstitial space and the brain cells are tradition-
ally considered as a single kinetic compartment, consistent with 
similar intra- and extracellular glucose concentrations (Pfeuffer 
et al., 2000; Poitry-Yamate et al., 2009). In these conditions, a model 
can be designed as shown in the scheme of Figure 1C, adding the 
endothelial compartment to the model of Figure 1B. The endothe-
lium was taken as a ﬁ  nite compartment and much smaller than the 
compartment constituted by brain cells (Simpson et al., 2007), and 
endothelial glucose consumption was neglected.
At steady-state, glucose transport is now represented by the fol-
lowing mathematical expressions:
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where Gend is the glucose concentration in the endothelial com-
partment (in µmol  g−1), and T are the unidirectional ﬂ  uxes 
depicted in Figure 1C (in µmol g−1 min−1). By inserting Eq. 2 Frontiers in Neuroenergetics  www.frontiersin.org  October  2009 | Volume  1 | Article  6 | 4
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in Eq. 5, and assuming symmetric transport properties for 
both membranes of the endothelial compartment, we arrive at 
the expression:
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relating Gbrain and Gplasma at steady-state, and accounting for the effect of 
the inclusion of the endothelial compartment in the model. As above, 
when Kii largely exceeds Gplasma we obtain an equation equivalent to the 
corresponding formulation of reversible MM kinetics (see Appendix 
in Gruetter et al., 1998). Interestingly, by rearranging the components 
of this equation, we can create an expression with the same algebraic 
typology of Eq. 4, which assumed a single membrane at the BBB:
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Comparing this expression to Eq. 4, we can infer that the maxi-
mum rate of glucose diffusion in the overall process is affected by 
both Kt and Kii. In this model that includes two membranes deﬁ  ning 
the endothelial compartment, the calculated Tmax for glucose uptake 
represents the maximum transport rate at each membrane and 
not for the global mechanism, and hence Tmax will have a different 
value from the single-membrane model. The kinetic constants Kt 
and Kii have the same value either the model is extended to include 
the endothelium or not.
ESTIMATION OF KINETIC PARAMETERS AND STATISTICAL ANALYSIS
Previously published relationships of Gbrain to Gplasma were ﬁ  tted with 
the obtained analytical Eqs 4 and 6. In particular, the model was 
tested with results acquired in vivo by localized 1H NMR spectros-
copy from human subjects (Gruetter et al., 1998) and rats (Choi 
et al., 2002; Lei and Gruetter, 2006), and measured with biochemical 
assays (Morgenthaler et al., 2006; Poitry-Yamate et al., 2009).
Data analysis was performed with GraphPad Prism 4 (GraphPad 
Software, CA, USA). The entire range of measured values in each 
data set was ﬁ  tted using a non-weighted minimization of the 
sum of squares. The F-test was used to compare the ﬁ  t of the 
currently described four-state conformational model with the 
reversible MM model.
Transport was described by four parameters: apparent half satu-
ration constant Kt, apparent maximum rate constant Tmax, the iso-
inhibition constant Kii, and glucose consumption rate CMRglc. Tmax 
was estimated relatively to a constant CMRglc, which was assumed 
to not vary over the range of glucose concentrations studied. 
The determined kinetic parameters were compared to the values 
obtained with the standard and reversible models reported in the 
respective studies (Gruetter et al., 1998).
The kinetic parameters describing brain glucose transport were 
determined with from published data sets (Gruetter et al., 1998; 
Choi et al., 2002; Morgenthaler et al., 2006), which are plots of brain 
glucose concentration measured as function of plasma glucose.
RESULTS
Table 1 summarises the kinetic parameters determined with the 
four-state conformational model with or without the endothelial 
compartment, and with the reversible and standard MM models. 
Including the endothelial compartment in the model, glucose trans-
port at the BBB was characterized by Kt ranging from 1.5 to 3.5 mM, 
Tmax/CMRglc from 4.6 to 5.6, and Kii from 51 to 149 mM.
The comparison of the ﬁ  t quality of the present four-state con-
formational model with the reversible MM model to these data sets 
is shown in Figure 2. The ﬁ  tting of these three data sets with the 
conformational and the reversible models was not signiﬁ  cantly dif-
ferent (F = 0.18 and P = 0.68 for Figure 2A, F = 0.62 and P = 0.42 
Table 1 | Kinetic parameters estimated from the data shown in Figure 2. The reversible and standard models used for the determination of these kinetic 
parameters were developed for a single membrane system. Data is shown together with standard error and conﬁ  dence interval.
 Model  Tmax/CMRglc  Kt (mM)  Kii (mM)
Gruetter et al., 1998 Reversible  2.3  ± 0.2 (1.9–2.8)  0.6 ± 2.0 (3.6–4.8)  –
 Four-state  conformation  2.7  ± 1.2 (0.2–5.2)  2.1 ± 5.2 (0–12.6)  50.8 ± 161.5 (0–381.2)
  Four-state conform. with endothelium  5.2 ± 2.5 (0–10.5)  2.1 ± 5.2 (0–12.6)  50.8 ± 161.5 (0–381.2)
 Standard  4.5  ± 0.2 (4.0–5.0)  9.0 ± 2.2 (4.4–13.5)  –
Choi et al., 2002 Reversible  2.7  ± 0.1 (2.5–2.8)  2.9 ± 0.5 (1.9–3.9)  –
 Four-state  conformation  2.9  ± 0.3 (2.3–3.4)  3.5 ± 1.0 (1.6–5.4)  105.3 ± 151.7 (0–406.5)
  Four-state conform. with endothelium  5.6 ± 0.6 (4.4–6.7)  3.5 ± 1.0 (1.6–5.4)  105.3 ± 151.7 (0–406.5)
 Standard  4.7  ± 0.1 (4.5–4.9)  9.3 ± 0.6 (8.1–10.5)  –
Morgenthaler et al., 2006 Reversible  2.3  ± 0.1 (2.1–2.5)  1.4 ± 0.7 (−0.1–2.8) –
 Four-state  conformation  2.4  ± 0.4 (1.7–3.1)  1.5 ± 1.1 (0–3.7)  145.9 ± 776.4 (0–1696.0)
  Four-state conform. with endothelium  4.6 ± 0.8 (3.0–6.2)  1.5 ± 1.1 (0–3.7)  145.9 ± 776.4 (0–1696.0)
 Standard  4.1  ± 0.1 (3.9–4.3)  5.3 ± 0.8 (3.7–6.9)  –Frontiers in Neuroenergetics  www.frontiersin.org  October  2009 | Volume  1 | Article  6 | 5
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for Figure 2B, F = 0.03 and P = 0.86 for Figure 2C). Therefore the 
reversible MM model that has one less unknown parameter may 
be preferable for the description of glucose transport in these par-
ticular cases.
We observed that the current model can fail to reliably describe 
glucose transport in cases where Gbrain was studied over a more lim-
ited range of Gplasma or if data was absent at lower Gplasma (Figure 3A). 
In such cases, lacking the initial values that deﬁ  ne the experimental 
curve, Kii tends to equal Kt leading to kinetics that is similar to the 
standard MM model. For the particular data set of Figure 3A (Lei 
and Gruetter, 2006), Tmax/CMRglc was 9.2 ± 5.5 (0–20.2) and Kt was 
8.8 ± 11.1 (0–31.0) mM. On the other hand, when data was mainly 
composed of measurements at low Gplasma and few high Gplasma, Kii 
tends to inﬁ  nity and the ﬁ  tting superimposes the reversible MM 
model. This case is exempliﬁ  ed in Figure 3B (Poitry-Yamate et al., 
2009), where Tmax/CMRglc was 4.9  ± 0.4  (4.0–5.7)  and  Kt was 
4.1 ± 1.3 (1.5–6.7) mM.
DISCUSSION
The present work derives a single analytical expression that describes 
steady-state glucose transport across the BBB using a model of a 
carrier with four possible conformations, including isomerisation 
of the loaded or unloaded carrier and glucose binding or dissocia-
tion at both sides of the membrane. This model was described by 
a Kt on the order of a few mM, as previously determined from the 
reversible model, and an iso-inhibition constant Kii that largely 
exceeds Gplasma, suggesting a week inhibitory role of Gbrain on glu-
cose uptake.
The system was ﬁ  rst described as a single membrane at the BBB 
and then extended to include the endothelial cells as a compartment 
representing the BBB. The equations of the overall process in each 
of these models are algebraically equivalent and only differ in the 
estimated Tmax of glucose transport that has a two-fold different 
value and thus must have a different interpretation: the apparent 
maximum rate of glucose transport was approximately doubled 
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FIGURE 2 | Brain glucose concentration as function of plasma glucose 
concentration in three different studies. (A) Human brain, in Gruetter et al. 
(1998); (B) rat brain (under α-chloralose anaesthesia), in Choi et al. (2002); 
(C) rat brain, in Morgenthaler et al. (2006). The data sets were analysed with 
the reversible (solid lines) and the conformational four-state exchange (dashed 
lines) models (see kinetic parameters in Table 1). In these experimental 
conditions and for the range of glucose concentrations studied, the reversible 
MM model is clearly able to describe the brain-blood glucose relationship, with 
the advantage of requiring the estimation of only two 
kinetic parameters.
01 0 2 0 3 0 4 0
0
2
4
6
8
10
12
Plasma glucose (mM)
C
o
r
t
i
c
a
l
 
g
l
u
c
o
s
e
 
(
μ
m
o
l
/
g
)
01 0 2 0 3 0 4 0
0
2
4
6
8
10
12
Plasma glucose (mM)
B
r
a
i
n
 
g
l
u
c
o
s
e
 
(
μ
m
o
l
/
g
)
AB
FIGURE 3 | Brain glucose concentration as function of plasma 
glucose concentration in two extreme cases, when the 
experimental curve is ill-deﬁ  ned at lower (A) or higher (B) 
plasma glucose concentrations. In panel (A), the model takes 
the form of the standard MM model (results from the whole rat brain 
reported in Lei and Gruetter, 2006); in panel (B), the model superimposes 
the reversible MM model (results from the rat cortex reported in 
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when the endothelial compartment was included,   representing 
the   maximum transport at each membrane and not  for the 
overall transport   process. As expected from previous studies 
(Pappenheimer and Setchell, 1973; Gruetter et al., 1998), kinetic 
constants   reﬂ  ecting substrate afﬁ  nity (Kt and Kii) were not affect-
ed by the extension to include the endothelial compartment.
These compartmental models may also be described to include 
asymmetry of the glucose carrier kinetics. This does not affect 
the algebraic form and thus the ﬁ  tting of the model to the rela-
tion between brain and plasma glucose concentrations. However, 
increasing the number of kinetic constants in such expres-
sion did not allow a reliable estimation of all the parameters 
as the inherent degrees of freedom are insufﬁ  cient. For such 
models a numerical analysis would be preferred in detriment 
of using a single analytical expression to describe the glucose 
transport mechanism.
Since the concentration of carriers in cerebral cells is much 
higher than at the BBB, interstitial space together with neurons 
and glia were considered to form a single kinetic compartment, 
as in traditional kinetic models (e.g. Cunningham et al., 1986; 
Mason et al., 1992; Gruetter et al., 1998). Nevertheless, we noted 
that the inclusion of the interstice as an extra compartment at 
the BBB, separated from brain cells, also allowed the development 
of a single equation algebraically similar to the equations for 
simpler models (see Eq. A9), even when different concentration 
of glucose carriers were considered at the membrane of brain 
cells. We found that the number of metabolic compartments was 
directly associated with an increase in the degree of complex-
ity in the dependence of maximum rate of the global diffusion 
process from the other kinetic constants. Since it did not provide 
additional knowledge on the system, this model was not tested 
with experimental data.
Astrocytic processes are in direct contact with blood vessels, 
thus some models were developed to include an astrocytic com-
partment which is separated from neuronal cells and included in 
a gliovascular unit (Barros et al., 2007; Simpson et al., 2007). To 
describe substrate dynamics in this gliovascular unit, not only 
glucose concentrations but also the concentration of products of 
its metabolism in plasma and/or brain would be required, in par-
ticular pyruvate and lactate. In addition, carriers for monocarboxy-
lates that are responsible for eventual pyruvate/lactate exchange 
The apparent Michaelis constant Kt was found to be on the 
order of a few mM, as previously determined with the reversible 
model (Gruetter et al., 1998). The present model of glucose diffu-
sion into the brain includes both efﬂ  ux and transport inhibition 
by Gbrain, predicting that Gbrain eventually approaches a maximum 
when it is higher than Kii. However, since Kii largely exceeds Kt 
and the concentration of physiological brain glucose concentra-
tions, iso-inhibition is unlikely to be of substantial importance 
when plasma glucose is below 25 mM. This suggests that the 
reversible model can account for most experimental observa-
tions under physiological conditions. In fact, the ﬁ  t of experi-
mental data (Figure 2) was not statistically different with the 
four-state conformational model and the reversible MM model 
previously proposed (Gruetter et al., 1998). However, in metabolic 
conditions where high glucose   concentrations are observed (for 
example under eventual   uncontrolled   diabetes), the inhibition 
constant Kii may be important in   describing glucose transport 
at the BBB.
In conclusion, the four-state conformational model to describe 
steady-state brain glucose concentration resulted in an inhibition 
constant that largely exceeds the observed glucose concentrations, 
implying a fast isomerisation between unloaded carrier forms. We 
further conclude that kinetic parameters of glucose transport are 
closely determined by the reversible model when physiological 
ranges of plasma glucose are studied. Finally, well deﬁ  ned experi-
mental curves of Gbrain as a function of Gplasma covering broad con-
centration ranges are of advantage for an adequate estimation of 
all the kinetic parameters.
APPENDIX
(A) DERIVATION OF THE NET VELOCITY EQUATION FOR THE FOUR-STATE 
EXCHANGE MODEL
In the present work, the four-state conformational model was 
described without any assumption on the rate constants (ki) of 
the isomerisation between the four conformations of the glucose 
carrier. The derivation of the net velocity equation for the trans-
port mechanism depicted in Figure 1A using the King-Altman 
method (King and Altman, 1956) results in the following  expression 
(Eq. A1) that includes the rate constants for all the possible reac-
tions of isomerisation between the four carrier forms:
between cells should be included in all the membranes involved, 
as detailed in the model described by Simpson et al. (2007). Our 
model included glial cells together with neurons in the metabolic 
compartment without specifying where glucose is mostly con-
sumed, which was able to adequately describe glucose dynamics 
at the BBB. To support this, it is known that glucose carriers exist 
at higher concentration in the membrane of these cells than at 
the BBB (reviewed in Simpson et al., 2007) such that glucose is 
evenly distributed in brain’s aqueous phase (Pfeuffer et al., 2000; 
Poitry-Yamate et al., 2009).
v
C
kkkkG k k k k G
kk k k k kk k
0 1234 1 2 3 4
44 1 2 2 3 3 [] t
out in =
− −−−−
−− − + ()++ − −− − − − − − − − − () ++ + + () ++ + 1 3 12 24 24 14 1 4 2 42 3 4 k k kk kk kk k Gk k k k kk k in + + () ++ () −− kk G k kk kk G G 23 3 1 2 12 out in out
(A1)
where [C]t represents the total carrier concentration.
The use of Cleland’s (1963) method allows replacing rate con-
stants by kinetic parameters that can be determinate experimentally, 
leading to the following net velocity equation:
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This is the Eq. 1 on which our model was based. Being the deri-
vation made without any assumption on the relative values of rate 
constants ki (Figure 1A), the kinetic parameters are deﬁ  ned by the 
algebraic solutions shown in Table A1.
Note that when rewriting Eq. A2 (with Keq = 1) in a form that 
is algebraically equivalent to the equation that expresses transport 
in terms of an afﬁ  nity term K and four resistant terms Roo, Ree, Rio 
and Roi (e.g. Stein, 1986; Carruthers, 1991; Simpson et al., 2007) 
the following expression is obtained:
v
GG
K
V
K
VK
G
G
V
GG
V
GG
G
0 =
−
++ +
out in
MM
M
in
out out in
out out
in
max max max m maxKii  
(A2a)
from which the kinetic constants used in the present paper can be 
directly related to the resistance parameters, i.e. KK R R
G
Mo o i o
in = /,  
KK R R
G
Mo o o i
out = /,   Vmax = 1/Roi,  Kii = KRoi/Ree and VR max /
r
io = 1  
(through Keq = 1).
It should be further noted that when Gbrain = 0, correspond-
ing to zero-trans transport, Eq. A2 is identical to the standard 
Michaelis-Menten expression, and therefore Vmax and KM are 
equivalent to the corresponding constants measured in zero-
trans experiments.
(B) DERIVATION OF THE FOUR-STATE CONFORMATIONAL MODEL 
ASSUMING FAST ISOMERISATION OF THE UNLOADED CARRIER
This section of the appendix aims to show that fast isomeri-
sation between unloaded carrier conformations is equivalent 
to the reversible MM model of glucose transport. In Section 
“Derivation of the Net Velocity Equation for the Four-State 
Exchange Model” in Appendix we derived the net velocity equa-
tion of the glucose carrier without any assumption on the rela-
tive rate constants ki (Figure 1A). However, if the isomerisation 
between unloaded carrier forms is faster than all the other con-
formational alterations, i.e. k4 and k−4 are much larger than the 
rate constants for the other reactions, by dividing both numera-
tor and denominator by k4 + k−4, the net velocity equation A1 
can be approximated by:
v
C
kkkG k k k G
kk k k k k k k k
0
123 1 2 3
12 2 3 31 3 2
[] t
out in
=
−
++ () ++
−−−
−− − − − 2 21 1 22 3 + ( ) ++ + () −− kG k k k k G in out 
 (A3)
When this expression is treated using the deﬁ  nitions proposed 
by Cleland (1963), the net velocity equation is given by:
v
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(A4)
where the kinetic parameters are deﬁ  ned by the rate constants as 
shown in Table A2.
Such enzymatic system is formally equivalent to a sim-
ple reversible MM mechanism with two central complexes in 
which the conversion of substrate (Gout) into product (Gin) are 
considered distinct reactions (Leskovac, 2003). Hence, a fast 
isomerisation of the unloaded carrier in comparison to the 
other conformational changes is mathematically equivalent to 
an enzymatic mechanism comprising a single conformation for 
the unloaded carrier. The difference between Eqs 1 and A4 is the 
absence of the term containing Kii in the latter. This observation 
suggests that Kii is an inhibition constant that reﬂ  ects the action 
of Gin as inhibitor of the isomerisation of the unloaded carrier, 
probably by stabilization of the carrier in the conformation that 
favours binding of Gin.
The insertion of Eq. A4 in Eq. 3, for a system described in 
Figure 1B with symmetric glucose carriers and satisfying the 
steady-state condition, originates the equation that describes 
the reversible MM model of glucose transport (Gruetter 
et al., 1998):
GV
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CMR
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T
CMR
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glc
plasma t
glc
=
−
⎛
⎝
⎜
⎞
⎠
⎟ −
+
max
max
1
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(A5)
Table A1 | Kinetic parameters for rate transport and substrate afﬁ  nity 
used in Eq. A2 (or Eq. 1) described in terms of the individual rate 
constants for the transport diagram in Figure 1A.
Parameter Deﬁ  nition  Algebraic solution
Vmax
f   Maximum velocity of 
kkk
kk kk kk kk
C
234
42 4 2 34 23 ++ + () []
−
t
  the forward transport 
K
G
M
in   Michaelis constant for 
kk k k k kk k
k k kk kk kk k
441 2 2 3 3 1
31 2 2 4 2 4 1 4
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K
G
M
out   Michaelis constant for 
kk k k k kk k
kk k k k k k k k
441 2 2 3 3 1
1 4 24 23 42 3
+ () ++ ()
++ + ()
−− − −
−   the forward transport 
Kii   Iso-inhibition constant  
kk k k k k k k k
kk k k k
1 4 24 23 42 3
31 2 1 2
++ + ()
+ ()
−
−−
Keq  Equilibrium  constant 
kkkk
kkkk
1234
1234 −−−−   for the overall reaction 
Table A2 | Kinetic parameters for rate transport and substrate afﬁ  nity 
used in Eq. A4 described in terms of the individual rate constants for the 
transport diagram in Figure 1A.
Parameter Deﬁ  nition  Algebraic solution
Vmax
f   Maximum velocity of the 
kk
kk k
C
23
22 3 ++ []
−
t
 forward  transport 
K
G
M
in   Michaelis constant for the 
kk k k k k
kk kk
−− −
−− −
++
++ ()
12 2 3 31
32 2 1  reverse  transport 
K
G
M
out   Michaelis constant for the 
kk k k k k
kk k k
−− −
−
++
++ ()
12 2 3 31
12 2 3  forward  transport 
Keq   Equilibrium constant for the 
kkk
kkk
123
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(C) ASYMMETRY OF THE CARRIER
Both standard and reversible MM models of glucose transport 
traditionally assumed facilitated diffusion through symmetric 
carrier proteins at the several membranes composing the BBB 
(e.g. Gruetter et al., 1998). Experiments performed in vivo in a 
non-invasive way measured only two variables (Gbrain and Gplasma), 
which restricts the number of kinetic constants that can be directly 
determined and used to describe glucose dynamics at the BBB. 
Nevertheless, the effect of the existence of asymmetry in the glucose 
carriers can be analysed.
As found in the present study, the number of compartments 
composing the BBB did not affect the arithmetic form of the rela-
tion between brain and plasma glucose concentrations. Thus, for 
the sake of example, the single-membrane model was used to test 
for potential effects of the presence of asymmetric glucose carriers 
at the BBB. The combination of Eqs 1 and 3 results in the following 
expression that includes different apparent Michaelis constants for 
the transport in each direction.
GV
T
CMR
GK
T
CMR
K
G
G brain d
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glc
t
plasma
=
−
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⎜
⎞
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1
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brain brain
t
plasma
ii K
G
K
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(A6)
In this equation, Tmax is the apparent maximum velocity of 
the forward transport, and K
G
t
plasma and K
G
t
brain are the apparent 
Michaelis constants for the forward and reverse transports. Note 
that Keq was assumed 1 for facilitated diffusion (Cuppoletti and 
Segel, 1975).
The data set in Figure 2A was used as example to test the effect 
of asymmetry. As shown in Table A3, the value of Tmax/CMRglc 
is more resistant to variations of the ratio KK
G G
tt
plasma brain /  when K
G
t
plasma 
is smaller than K
G
t
brain, rather than when K
G
t
plasma exceeds. Moreover, 
the estimated kinetic parameters are less affected by asymmetry 
when Kii is constrained to 51 mM (value obtained for symmet-
ric transport). In any case, for a constant CMRglc, Tmax increased 
with the increment of K
G
t
plasma relative to K
G
t
brain, suggesting that if 
  asymmetry is considered there is higher afﬁ  nity for glucose in the 
brain than in plasma.
(D) TRANSPORT MODEL INCLUDING BOTH ENDOTHELIAL AND 
INTERSTITIAL COMPARTMENTS
The four-state conformational model of glucose transport was 
described either assuming a single membrane at the BBB or includ-
ing the endothelium as an extra compartment. The complexity of 
the BBB can take other compartments as is the case of the interstitial 
space between the endothelium and the brain cells, which occupies 
20% of the total brain volume (Hrabetová and Nicholson, 2004). 
The addition of the interstitium, i.e a third compartment, to the 
model of glucose diffusion across the BBB (Figure 1C), requires 
the inclusion of a new pair of unidirectional ﬂ  uxes [T(3) and T(−3)] 
that represent glucose transport at brain cell membranes. At steady-
state, the process is described by:
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(A7)
where Gint is the glucose concentration in the interstitial com-
partment (in µmol g−1), and T are the unidirectional ﬂ  uxes (in 
µmol g−1 min−1) at each membrane (take Figure 1C as example).
The distribution of the glucose carriers is certainly not uniform 
at all membranes. As discussed in Barros et al. (2007), the number 
of glucose carriers is higher at the membrane of brain cells than 
in endothelial membranes, which directly affects the value of Tmax. 
Thus, the factor n was introduced to reﬂ  ect the relative concentra-
tion of carriers at those membranes. Assuming symmetric transport 
properties for all membranes involved in the model, the insertion 
of Eq. 2 in the Eq. A7 originate the following expressions:
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(A8)
Note that Gend and Gint are also affected by their respective dis-
tribution volumes, but they were omitted for simpliﬁ  cation. These 
equations can be solved to produce the expression A9 that relates 
Gbrain and Gplasma at steady-state.
Table A3 | Effect of asymmetry of the glucose carrier on the estimated 
kinetic parameters.
 All  parameters  ﬁ  tted without   Kii ﬁ  xed at 51 mM
 any  constraint
KK
G G
tt
plasma brain /  Kii (mM)  K
G
t
plasma (mM)  Tmax/CMRglc  K
G
t
plasma (mM)  Tmax/CMRglc
0.01  101  1.0 1.9 1.7 2.0
0.1  92  1.1 1.9 1.8 2.1
0.5 68  1.5  2.3 1.9 2.4
0.7 60  1.8  2.4 2.0 2.5
0.9 54  2.0 2.6 2.0 2.6
1  51  2.1 2.7 2.1 2.7
1.1 48  2.2 2.8 2.1 2.8
1.3 44  2.4 3.1 2.2 2.9
1.5 41  2.6 3.6 2.2 3.0
2  34  3.1 6.1 2.4 3.4
10 9.0  11.4  10.4  4.8  8.6
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Equation A9 is formally equivalent to Eqs 4 and 6 (here con-
veniently shown in the form of Eq. 7) obtained for a model that 
either is composed of a single membrane at the BBB or includes 
the endothelial compartment. In fact, in the case of considering 
the number of carriers at the cellular membrane of astrocytes and 
neurons much larger than in the endothelial cells, i.e. if n is con-
sidered inﬁ  nite, this equation will be approximate Eq. 6 (or 7), 
which includes the endothelial compartment at the BBB (scheme of 
Figure 1C). The apparent maximum transport rate Tmax estimated 
with Eq. A8 will differ from the other models, being affected by the 
ﬂ  ux at each carrier involved and the relative carrier concentrations 
at each membrane of the BBB. Kt and Kii have the same value as 
in the other models. For n = 10, i.e. when carriers exist at ﬁ  ve-fold 
higher concentration in brain cells than in endothelial membranes, 
as it was assumed in the model described by Barros et al. (2007), 
Eq. A9 becomes:
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